Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Invion ( (AU:IVX) ) is now available.
Invion Limited announced a change in the interests of its director, Alan Yamashita, who acquired 115,541 listed share options through participation in an entitlement offer. This change reflects a strategic move within the company’s governance, potentially impacting its market positioning and shareholder interests.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on the development of treatments for chronic inflammatory diseases. The company is engaged in research and development activities aimed at creating innovative therapeutic solutions.
Average Trading Volume: 115,616
Technical Sentiment Signal: Sell
Current Market Cap: A$8.49M
Learn more about IVX stock on TipRanks’ Stock Analysis page.